One-year follow-up after implantation of the EverFlex nitinol stent in long lesions of the superficial femoral artery

Angiology

Volumn 60, Issue 1, 2009, Pages 31-35

  Ruef, Johannes ^a  

^a Red Cross Hospital   (Germany)

Author keywords

EverFlex stent; Long lesions; Superficial femoral artery

Indexed keywords

NITINOL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CORONARY STENT; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; STENOSIS; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 59149083488     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708317336     Document Type: Article

References (17)

1. Vogel TR, Shindelan LE, Nackman GB, et al. Efficacious use of nitinol stents in the femoral and popliteal arteries. J Vasc Surg. 2003 ; 38: 1178-1184.
2. Ruef J., Hofmann M., Haase J. Endovascular interventions in iliac and infrainguinal occlusive artery disease. J Interv Cardiol. 2004 ; 17: 427-435.
3. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal balloon angioplasty. J Vasc Surg. 1997 ; 25: 74-83.
4. Schillinger M., Sabeti S., Dick P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007 ; 115: 2745-2749.
5. Krankenberg H., Schlüter M., Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007 ; 116: 285-292.
6. Norgren L., Hiatt WR, Dormandy JA,, et al. for the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007 ; 33 (suppl 1). S1 - S75.
7. Sabeti S., Mlekusch W., Amighi J., et al. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther. 2005 ; 12: 6-12.
8. Schilliger M., Minar E. Endovascular stent implantation for treatment of peripheral artery disease. Eur J Clin Invest. 2007 ; 37: 165-170.
9. Mewissen MW Stenting in the femoropopliteal arterial segment. Tech Vasc Interv Radiol. 2005 ; 8: 146-149.
10. Sabeti S., Czerwenka-Wenkstetten A., Dick P., et al. Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. J Endovasc Ther. 2007 ; 14: 431-437.
11. Cho L., Roffi M., Mukherjee D., et al. Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty alone. J Invasive Cardiol. 2003 ; 15: 198-200.
12. Schlager O., Dick P., Sabeti S., et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther. 2005 ; 12: 676-684.
13. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005 ; 46: 312-315.
14. Ruef J., Hofmann M., Haase J. Initial clinical experience with the Protégé EverFlex long self-expanding nitinol stent in the superficial femoral artery. J Interv Cardiol. 2006 ; 19: 544-546.
15. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006 ; 354: 1879-1888.
16. Ferreira M., Lanziotti L., Monteiro M., et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg. 2007 ; 34: 702-708.
17. Rocha-Singh KJ, Jaff MR, Crabtree TR, et al. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007 ; 69: 910-919.